1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF FEMININE HYGIENE MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL FEMININE HYGIENE MARKET SNAPSHOT
3.2 GLOBAL FEMININE HYGIENE MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL FEMININE HYGIENE MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 SANITARY PADS
5.3 TAMPONS
5.4 PANTY LINERS
5.5 FEMININE HYGIENE WASH
5.6 MENSTRUAL CUP
5.7 DISPOSABLE RAZORS AND BLADE
6 GLOBAL FEMININE HYGIENE MARKET, BY DISTRIBUTION CHANNELS
6.1 OVERVIEW
6.2 SUPERMARKETS/HYPERMARKETS
6.3 PHARMACIES & BEAUTY STORES
6.4 DRUG STORES
6.5 CONVENIENCE STORES
6.6 ONLINE PURCHASE
7 GLOBAL FEMININE HYGIENE MARKET, BY GEOGRAPHY
7.1 NORTH AMERICA
7.1.1 MARKET DYNAMICS
7.1.1.1 DRIVERS
7.1.1.2 RESTRAINS
7.1.1.3 OPPORTUNITY
7.1.2 U.S.
7.1.3 CANADA
7.1.4 MEXICO
7.2 EUROPE
7.2.1 MARKET DYNAMICS
7.2.1.1 DRIVERS
7.2.1.2 RESTRAINS
7.2.1.3 OPPORTUNITY
7.2.2 U.K.
7.2.3 FRANCE
7.2.4 GERMANY
7.2.5 SPAIN
7.2.6 REST OF EUROPE
7.3 ASIA PACIFIC
7.3.1 MARKET DYNAMICS
7.3.1.1 DRIVERS
7.3.1.2 RESTRAINS
7.3.1.3 OPPORTUNITY
7.3.2 INDIA
7.3.3 CHINA
7.3.4 JAPAN
7.3.5 REST OF ASIA PACIFIC
7.4 MIDDLE EAST AND AFRICA
7.4.1 MARKET DYNAMICS
7.4.1.1 DRIVERS
7.4.1.2 RESTRAINS
7.4.1.3 OPPORTUNITY
7.4.2 SOUTH AFRICA
7.4.3 REST OF MIDDLE EAST AND AFRICA
7.5 LATIN AMERICA
7.5.1 MARKET DYNAMICS
7.5.1.1 DRIVERS
7.5.1.2 RESTRAINS
7.5.1.3 OPPORTUNITY
7.5.2 BRAZIL
7.5.3 REST OF LATIN AMERICA
8 GLOBAL FEMININE HYGIENE MARKET, BY COMPANY
8.1 INTRODUCTION
8.2 KIMBERLEY-CLARK CORPORATION
8.2.1 BUSINESS OVERVIEW
8.2.2 PRODUCTS & SERVICES
8.2.3 KEY STRATEGY
8.2.4 RECENT DEVELOPMENTS
8.2.5 SWOT ANALYSIS
8.3 JOHNSON & JOHNSON
8.3.1 BUSINESS OVERVIEW
8.3.2 PRODUCTS & SERVICES
8.3.3 KEY STRATEGY
8.3.4 RECENT DEVELOPMENTS
8.3.5 SWOT ANALYSIS
8.4 UNICHARM CORPORATION
8.4.1 BUSINESS OVERVIEW
8.4.2 PRODUCTS & SERVICES
8.4.3 KEY STRATEGY
8.4.4 RECENT DEVELOPMENTS
8.4.5 SWOT ANALYSIS
8.5 PROCTER & GAMBLE
8.5.1 BUSINESS OVERVIEW
8.5.2 PRODUCTS & SERVICES
8.5.3 KEY STRATEGY
8.5.4 RECENT DEVELOPMENTS
8.5.5 SWOT ANALYSIS
8.6 EDGEWELL PERSONAL CARE
8.6.1 BUSINESS OVERVIEW
8.6.2 PRODUCTS & SERVICES
8.6.3 KEY STRATEGY
8.6.4 RECENT DEVELOPMENTS
8.6.5 SWOT ANALYSIS
8.7 ONTEX
8.7.1 BUSINESS OVERVIEW
8.7.2 PRODUCTS & SERVICES
8.7.3 KEY STRATEGY
8.7.4 RECENT DEVELOPMENTS
8.7.5 SWOT ANALYSIS
8.8 HENGAN INTERNATIONAL GROUP CO. LTD.
8.8.1 BUSINESS OVERVIEW
8.8.2 PRODUCTS & SERVICES
8.8.3 KEY STRATEGY
8.8.4 RECENT DEVELOPMENTS
8.8.5 SWOT ANALYSIS
8.9 GLENMARK PHARMACEUTICALS
8.9.1 BUSINESS OVERVIEW
8.9.2 PRODUCTS & SERVICES
8.9.3 KEY STRATEGY
8.9.4 RECENT DEVELOPMENTS
8.9.5 SWOT ANALYSIS
8.10 ENERGIZER HOLDINGS INC.
8.10.1 BUSINESS OVERVIEW
8.10.2 PRODUCTS & SERVICES
8.10.3 KEY STRATEGY
8.10.4 RECENT DEVELOPMENTS
8.10.5 SWOT ANALYSIS
8.11 LIL-LETS UK LIMITED
8.11.1 BUSINESS OVERVIEW
8.11.2 PRODUCTS & SERVICES
8.11.3 KEY STRATEGY
8.11.4 RECENT DEVELOPMENTS
8.11.5 SWOT ANALYSIS
8.12 BIOCHEMIX HEALTHCARE PRIVATE LIMITED
8.12.1 BUSINESS OVERVIEW
8.12.2 PRODUCTS & SERVICES
8.12.3 KEY STRATEGY
8.12.4 RECENT DEVELOPMENTS
8.12.5 SWOT ANALYSIS